Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform

HONG KONG, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has successfully completed a HK$150 million share placement, strengthening its balance sheet to accelerate investment in artificial intelligence and platform upgrades.

The shares were priced at HK$3.32 per share, with the shares placed representing approximately 3.26% of the Company's enlarged issued share capital following completion of the subscription.

Fangzhou plans to allocate approximately 90% of the net proceeds after deducting related costs and expenses to accelerate development of the Company's AI-driven chronic disease management platform. This encompasses model development and optimization, infrastructure and computational resource expansion, talent recruitment across AI and clinical specialties, data collection and annotation and knowledge base development, and roll-out and marketing of AI-enhanced services to capture underserved ...